Kidney outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes
A meta-analysis on sarcopenia and the risk of mortality in patients with sepsis indicated that, compared with patients without sarcopenia, those with sarcopenia have higher early mortality risks (during hospitalization or within 1 month of illness), as well as increased mortality risks at 3-6 months after sepsis (11)
Currently, Bellwether trials are expected to begin in late 2026 or early 2027, but these dates may change
Director, Food Safety Laboratory Associate Research Professor [email protected]
Simple Summary Tirzepatide works by copying two natural gut hormones GLP-1 and GIP that help control hunger, cravings, and fullness
Omada provides specialized lifestyle and medication support for every part of a members health journey, so they can all achieve meaningful health outcomes